1GO9
Monitoring the structural Consequences of Phe12-->D-Phe12 and Leu15-->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for Design of CRH antagonists.
5'-d(*(bru)p*ap*gp*gp*gp*(bru)p*tp*ap*gp*gp*gp*t)-3' -
Include CSM | ||
Advanced Search | Browse Annotations |
RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.
All questions and comments will receive a response in a timely manner.